Drug
Relacorilant With Nab Paclitaxel
Relacorilant With Nab Paclitaxel: highest development phase Phase 1/2, developed by Corcept Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Corcept Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Relacorilant with nab-paclitaxel NCT02762981 | Phase 1/2 | Solid Tumors |
Latest
No recent events.
Follow Relacorilant With Nab Paclitaxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.